Holen Sie sich die Stockscreener-App
16.17
1.34%
-0.22
Schlusskurs vom Vortag:
$16.39
Offen:
$16.2649
24-Stunden-Volumen:
2,170
Relative Volume:
0.10
Marktkapitalisierung:
$1.14B
Einnahmen:
$376.88M
Nettoeinkommen (Verlust:
$2.52M
KGV:
533.66
EPS:
0.0303
Netto-Cashflow:
$49.32M
1W Leistung:
-1.52%
1M Leistung:
-2.71%
6M Leistung:
+22.69%
1J Leistung:
+72.39%
1-Tages-Spanne:
$16.17
$16.33
1-Wochen-Bereich:
$16.17
$16.98
52-Wochen-Spanne:
$8.60
$21.34
Pharming Group Nv Adr Stock (PHAR) Company Profile
Firmenname
Pharming Group Nv Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare PHAR vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHAR
Pharming Group Nv Adr
|
16.17 | 1.16B | 376.88M | 2.52M | 49.32M | 0.0303 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pharming Group Nv Adr Stock (PHAR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-09 | Eingeleitet | Jefferies | Buy |
Pharming Group Nv Adr Aktie (PHAR) Neueste Nachrichten
Pharming Group gears up to report Q4 earnings: What's in the cards? - MSN
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Decline in Short Interest - MarketBeat
Pharming Group to report first quarter 2026 financial results and provide business update on May 7 - GlobeNewswire Inc.
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Large Decline in Short Interest - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Pharming Group N.V. Investigated by the Portnoy Law Firm - GlobeNewswire
Pharming (NASDAQ: PHAR) updates 20-F with corrected CEO/CFO certifications - Stock Titan
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Up 33.9% in March - MarketBeat
Pharming Group (NASDAQ:PHAR) Given Buy Rating at HC Wainwright - defenseworld.net
PHARM.AS Stock Price, Quote & Chart | PHARMING GROUP NV (AMS:PHARM) - ChartMill
HC Wainwright Estimates Pharming Group Q3 Earnings - Defense World
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Growth in Short Interest - MarketBeat
HC Wainwright Predicts Pharming Group Q1 Earnings - MarketBeat
A2QLQY Stock Price and Chart — LS:A2QLQY - TradingView
Pharming Q4 2025 slides: profitability inflection drives 27% growth - Investing.com
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards? - Finviz
Pharming Group Prepares to Announce Q4 Results: What Can Investors Expect? - Bitget
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Drop in Short Interest - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V.PHAR - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - GlobeNewswire Inc.
FY2025 EPS Estimates for Pharming Group Increased by Analyst - Defense World
Pharming shares surge as 2026 guidance tops analyst expectations - Investing.com
Pharming Group stock tumbles after FDA issues Complete Response Letter - Investing.com
Pharming Group (NASDAQ:PHAR) Sets New 1-Year HighTime to Buy? - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group stock hits 52-week high at 18.6 USD - Investing.com
Pharming Group (NASDAQ:PHAR) Cut to Hold at Zacks Research - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap Down After Analyst Downgrade - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's What Happened - MarketBeat
Pharming Group (NASDAQ:PHAR) Trading Up 4.4% – Here’s Why - Defense World
Pharming Group (NASDAQ:PHAR) Hits New 1-Year High – Still a Buy? - Defense World
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Rises By 102.0% - MarketBeat
Pharming Group stock hits 52-week high at 18.19 USD - Investing.com
Best Momentum Stocks to Buy for Dec. 22 - Yahoo Finance Singapore
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Hits New 12-Month HighShould You Buy? - MarketBeat
Operating expenses (excl. COGS) of Pharming Group NV Sponsored ADR – LSX:A2QLQY - TradingView
Pharming Group (NASDAQ:PHAR) Stock Price Up 11%Time to Buy? - MarketBeat
Finanzdaten der Pharming Group Nv Adr-Aktie (PHAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):